AI Prescription Refill Agent
The AI Prescription Refill Agent handles incoming refill requests from patients—validating eligibility, checking refill limits, coordinating with pharmacy systems, and notifying patients of status. It processes requests 24/7 without human handoff for routine cases, routes complex scenarios to pharmacists, and integrates directly with your pharmacy management system. This removes friction from a high-volume, repetitive task that currently demands significant staff time.
How it works
ifolabs maps your pharmacy's refill workflows, SOP requirements, and integration points with your existing PMS or EHR system. We build the agent to handle identity verification, eligibility checks, and pharmacy system writes, then test against your actual workflows and compliance requirements before deploying to production.
Key benefits
Use cases
Frequently asked questions
Does the agent interface with pharmacy management systems?
Yes. We integrate directly with your PMS API or database to validate current medications, check refill counts, verify insurance, and log transactions. Common integrations include Pharmacy One, TriZetto, and custom NCPDP connections.
How does it handle controlled substances?
The agent identifies Schedule II–V drugs by NDC code and automatically routes those requests to a pharmacist for approval, rather than auto-processing. DEA refill rules (e.g., no refills for Schedule II) are enforced in logic.
What happens if the patient is not eligible for a refill?
The agent communicates the reason (no refills remaining, prior auth needed, insurance lapsed) to the patient via their preferred channel and alerts the pharmacy team with a ticket for manual follow-up.
Can it verify patient identity?
The agent uses multi-factor verification: phone number + date of birth cross-check, optional OTP via SMS, and lookup against your patient database. It does not store PII beyond session state.
Want this for your business?
Tell us what you'd like to automate — we'll reply with concrete next steps, no sales pitch.
Talk to us →